Connect Biopharmaceuticals

Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together

Connect reduces China workforce, mulls strategy for asthma drug

In a year that has seen Connect walk away from a Pfizer collab and halt preclinical work, the biotech is now “significantly reducing” its China presence

James Waldron Sep 6, 2024 4:37am

J&J, Bayer, Santa Ana, Regenxbio and more—Chutes & Ladders

Jun 14, 2024 8:30am

Connect uncouples from Pfizer by scrapping eczema pact

Apr 17, 2024 6:38am

Connect blames 'challenging environment' for lead program pause

Jan 3, 2023 7:55am

Chasing BMS and Pfizer, Connect fails ulcerative colitis trial

May 4, 2022 7:53am

Connect Biopharma touts positive data for Dupixent rival

Nov 22, 2021 5:30am